BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30125974)

  • 21. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells.
    Naveen CR; Gaikwad S; Agrawal-Rajput R
    Phytomedicine; 2016 Jun; 23(7):736-44. PubMed ID: 27235712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation.
    Meeran SM; Katiyar S; Katiyar SK
    Toxicol Appl Pharmacol; 2008 May; 229(1):33-43. PubMed ID: 18275980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth.
    Wang J; Peng Y; Liu Y; Yang J; Ding N; Tan W
    BMC Cancer; 2015 Aug; 15():595. PubMed ID: 26296751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis.
    Zhao Y; Jing Z; Li Y; Mao W
    Oncol Rep; 2016 Jul; 36(1):567-72. PubMed ID: 27177238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combinational effect of vincristine and berberine on growth inhibition and apoptosis induction in hepatoma cells.
    Wang L; Wei D; Han X; Zhang W; Fan C; Zhang J; Mo C; Yang M; Li J; Wang Z; Zhou Q; Xiao H
    J Cell Biochem; 2014 Apr; 115(4):721-30. PubMed ID: 24243568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
    Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
    Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death.
    Wang K; Zhang C; Bao J; Jia X; Liang Y; Wang X; Chen M; Su H; Li P; Wan JB; He C
    Sci Rep; 2016 Jun; 6():26064. PubMed ID: 27263652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of berberine on p53 expression by TPA in breast cancer cells.
    Kim S; Han J; Kim NY; Lee SK; Cho DH; Choi MY; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE
    Oncol Rep; 2012 Jan; 27(1):210-5. PubMed ID: 21964832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells.
    Abrams SL; Follo MY; Steelman LS; Lertpiriyapong K; Cocco L; Ratti S; Martelli AM; Candido S; Libra M; Murata RM; Rosalen PL; Montalto G; Cervello M; Gizak A; Rakus D; Mao W; Lombardi P; McCubrey JA
    Adv Biol Regul; 2019 Jan; 71():172-182. PubMed ID: 30361003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2.
    Wang Y; Zhang S
    Biomed Pharmacother; 2018 Jul; 103():1287-1293. PubMed ID: 29864910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Berberine: A novel therapeutic strategy for cancer.
    Samadi P; Sarvarian P; Gholipour E; Asenjan KS; Aghebati-Maleki L; Motavalli R; Hojjat-Farsangi M; Yousefi M
    IUBMB Life; 2020 Oct; 72(10):2065-2079. PubMed ID: 32735398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.
    Tsang CM; Cheung KC; Cheung YC; Man K; Lui VW; Tsao SW; Feng Y
    Biochim Biophys Acta; 2015 Mar; 1852(3):541-51. PubMed ID: 25496992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft.
    Mittal A; Tabasum S; Singh RP
    Phytomedicine; 2014 Feb; 21(3):340-7. PubMed ID: 24176840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Berberine suppresses TPA-induced fibronectin expression through the inhibition of VEGF secretion in breast cancer cells.
    Kim S; Oh SJ; Lee J; Han J; Jeon M; Jung T; Lee SK; Bae SY; Kim J; Gil WH; Kim SW; Lee JE; Nam SJ
    Cell Physiol Biochem; 2013; 32(5):1541-50. PubMed ID: 24335179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1.
    Zheng F; Wu J; Tang Q; Xiao Q; Wu W; Hann SS
    J Cell Mol Med; 2018 Jan; 22(1):600-612. PubMed ID: 28840963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway.
    Patil JB; Kim J; Jayaprakasha GK
    Eur J Pharmacol; 2010 Oct; 645(1-3):70-8. PubMed ID: 20691179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance.
    Mortazavi H; Nikfar B; Esmaeili SA; Rafieenia F; Saburi E; Chaichian S; Heidari Gorji MA; Momtazi-Borojeni AA
    Eur J Med Chem; 2020 Feb; 187():111951. PubMed ID: 31821990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells.
    Wang N; Wang X; Tan HY; Li S; Tsang CM; Tsao SW; Feng Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice.
    Xue M; Zhang L; Yang MX; Zhang W; Li XM; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
    Int J Nanomedicine; 2015; 10():5049-57. PubMed ID: 26346310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine: new perspectives for old remedies.
    Tillhon M; Guamán Ortiz LM; Lombardi P; Scovassi AI
    Biochem Pharmacol; 2012 Nov; 84(10):1260-7. PubMed ID: 22842630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.